Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year 2024, the company expected revenues to be $1,085 million - $1,105 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.15 USD | -2.80% |
|
-2.96% | -35.82% |
16/05 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
09/05 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.82% | 721M | |
-6.24% | 181B | |
-6.39% | 101B | |
-5.97% | 67.54B | |
-9.61% | 45.09B | |
+8.84% | 44.37B | |
+5.36% | 40.7B | |
+12.69% | 29.85B | |
+10.26% | 24.49B | |
-7.83% | 23.99B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024